Free Trial
NASDAQ:SBFMW

Sunshine Biopharma (SBFMW) Stock Price, News & Analysis

Sunshine Biopharma logo
$0.28 +0.08 (+38.89%)
Closing price 04/2/2025 03:59 PM Eastern
Extended Trading
$0.30 +0.02 (+7.14%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Sunshine Biopharma Stock (NASDAQ:SBFMW)

Key Stats

Today's Range
$0.19
$0.37
50-Day Range
$0.14
$0.80
52-Week Range
$0.04
$0.98
Volume
39,839 shs
Average Volume
18,686 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is headquartered in New York, New York.

Remove Ads
Receive SBFMW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter.

SBFMW Stock News Headlines

Sunshine Biopharma reports FY24 revenue $34.9M vs $24.1M last year
Sunshine Biopharma announces results from studies on K1.1-mRNA-LNP product
Trump to unlock 15-figure fortune for America (May 3rd) ?
We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public.
Sunshine Biopharma announces research results on K1.1 mRNA product
See More Headlines

SBFMW Stock Analysis - Frequently Asked Questions

Sunshine Biopharma's stock was trading at $0.1609 at the beginning of 2025. Since then, SBFMW shares have increased by 74.0% and is now trading at $0.28.
View the best growth stocks for 2025 here
.

Shares of SBFMW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SBFMW
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$32.96 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Spring 2025 Cover

Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.

Get This Free Report

This page (NASDAQ:SBFMW) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners